Brain metastases treatment with immunotherapy

Immune drugs help the patient's immune system recognize cancer cells so that the treatment can be used for brain metastases. Usually, the immune system destroys several million mutated cells every day. But sometimes, the strength of the immune response is not enough to kill cancer. As a result, malignant cells have learned to hide by secreting substances that prevent the immune system from finding them. Immune cells can easily overcome the blood-brain barrier and might be a good option for advanced cancer metastasis to the brain. Therefore, immune medications are often combined with chemo and targeted therapy. Today, the most promising immunotherapy regimen to treat brain metastases is a combination of Ipilimumab and Nivolumab. However, the choice of medications depends on the primary tumor's gene characteristics and previous treatment. Therefore, oncologists check for particular specs of your disease. As a rule, drugs are injected as an intravenous infusion. The first stage is designed to administer several doses of the drug at an interval of 3 weeks. Next, a control scan is performed, and an oncologist evaluates the treatment's effectiveness. If there is a response to immunotherapy, the treatment can be continued, or the physician might change medications.